Meyka AI API is live for developers.Start building.
Advertisement
Mydecine Innovations Group Inc.

Mydecine Innovations Group Inc. (MYCOF) Stock Overview

Explore Mydecine Innovations Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

MYCOF●PNK
HealthcareMedical - Pharmaceuticals
$2.00
$0.24(13.64%)
U.S. Market opens in 46h 28m
Advertisement

Mydecine Innovations Group Inc. (MYCOF)

Meyka AI Score

Z

Key Financials

Market Cap117.1M
P/E Ratio27.69
EPS (TTM)$1.82
ROE-0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$2.39
3 Months$0.32
1 Year Target$0.12

MYCOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mydecine Innovations Group Inc. (MYCOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 96.09, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.69 and a market capitalization of 117.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
13.64%
5-Day Change
85.19%
1-Month Change
100.00%
3-Month Change
1426.72%
6-Month Change
1983.33%
Year-to-Date (YTD) Change
817.43%
1-Year Change
40141.45%
3-Year Change
866.18%
5-Year Change
792.86%
All-Time (Max) Change
483.09%

Contact Information

https://www.mydecine.com
720-277-9879
789 West Pender Street, Vancouver, BC, V6E 3C9

Company Facts

3 Employees
IPO DateJan 8, 2021
CountryCA
Actively Trading

Frequently Asked Questions